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Neurodegenerative disorderIn this report, we describe the case of a new Japanese family (32 to 64 years old; 2 females and 1 male) affected
by adult-onset Alexander disease. Clinically, one member (age at onset, 56 years old) developed cerebellar
ataxia, another (age at onset, 55 years old) showed cerebellar ataxia and pseudobulbar signs, and one member
(32 years old) was asymptomatic. Marked atrophy of the medulla oblongata and spinal cord was detected in
the two symptomatic patients by magnetic resonance imaging (MRI). However, in the asymptomatic patient,
cervicomedullary atrophy was mild. Hyperintensity signals in the medulla oblongata were detected in the two
symptomatic patients, but not in the asymptomatic patient. In addition, there are symmetrical hyperintensity
signals in the posterior part of the globus pallidus on T2-weighted images in the two symptomatic patients,
which are rarely observed in adult-onset Alexander disease. Molecular genetic analysis revealed a novel mis-
sense mutation (p. D78N) in the glial ﬁbrillary acidic protein (GFAP) gene in this family. The typical atrophy of
themedulla oblongata and upper cervical cord detected byMRI is the diagnostic feature of adult-onset Alexander
disease. Genetic analysis of the GFAP gene is recommended for all patientswith late-onset progressive ataxia and
suspected of having adult-onset Alexander disease on the basis of MRI ﬁndings. Additionally, these characteristic
MRI patterns might even lead to the identiﬁcation of asymptomatic cases, as in one of our cases.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction
Alexander disease is a rare genetic disorder caused by mutations in
the gene encoding the glial ﬁbrillary acidic protein (GFAP) [1]. Clinical
subtypes of this disease have been distinguished according to the age
of onset: infantile (before 2 years of age), juvenile (until the middle
teens), and adult (late adolescence and beyond) [1,2]. The availability of
GFAP sequencing has increased diagnostic accuracy, and the obtained ev-
idence reveals that adult-onset Alexander disease is not so rare as com-
pared with the other types, and might even be the most common type.
The most frequent clinical symptoms of adult-onset Alexander dis-
ease are related bulbar dysfunction, pyramidal involvement, and cere-
bellar ataxia, but these clinical symptoms are usually not sufﬁciently
characteristic [3]. Each clinical subtype has characteristic magnetic res-
onance imaging (MRI) ﬁndings, and unique hyperintensity signals and
atrophy of themedulla oblongata and upper cervical cord onMR imagesishi-KobeMedical Center, 5-7-1
1 78 997 2200; fax:+81 78 993
.V. Open access under CC BY license.are highly characteristic ﬁndings of adult-onset Alexander disease [4,5].
Farina et al. [5] also suggested that MRI is the best diagnostic tool
for adult-onset Alexander disease and enables us to select patients for
genetic analysis.
Here, we describe the new cases of patients from a Japanese family
with adult-onset Alexander disease with not only the typical marked at-
rophy of themedulla oblongata and the spinal cord, but also the symmet-
rical involvement of the basal ganglia detected by MRI. These patients
showed a novel mutation in the GFAP gene.
2. Methods
2.1. Clinical study
Detailed interview and neurological examinations were performed
on three members (II:1, II:2, and III:2) of a Japanese family. All three
patients also underwent MRI of the brain. Computed tomography (CT)
of the brain was performed in only Patient 1.
2.2. Molecular study
The genetic testing of the siblings and one patient's son was
approved by the institutional review board of Jichi Medical University.
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ysis of their DNAwas performed by direct sequencing of thewhole gene
coding region as previously reported [4].
3. Results
3.1. Case reports
The family pedigree is shown in Fig. 1. Patient 1, a 64-year-old
woman (Fig. 1, II-1), presented with dysarthria at the age of 56. Six
years later, she developed gait disturbance. Shewas referred to our hospi-
tal at the age of 63.Hermother (Fig. 1, I-2) died at 84 after suffering froma
strikingly similar 14-year neurological disease. Therewas no consanguin-
eous marriage in their pedigree. Neurological examination revealed
slurred speech and truncal ataxia. Deep tendon reﬂexes were mildly in-
creased in all extremities, but pathological reﬂexes were absent. There
were no extrapyramidal signs. Her gait was wide-based, short-stepped,
and clumsy. There was no muscle weakness or atrophy and no palatal
myoclonus. Sensory and autonomic systems were normal.
Patient 2 was the younger sister of Patient 1 (2 years younger; Fig. 1,
II-2). At the age of 55, she noted dysarthria. Two years later, she devel-
oped progressive gait disturbance and dysphagia. At the age of 62, she
was admitted to our hospital and treated for dehydration,which required
percutaneous endoscopic gastrostomy. On admission, she had scoliosis.
Her cognitive functions were normal. She showed gaze-evoked nystag-
mus, slurred speech, and dysphagia. No tongue atrophy, fasciculation,
or palatal myoclonus was observed. There was no muscle weakness or
atrophy. Deep tendon reﬂexes were mildly increased in all extremities,
but pathological reﬂexes were absent. There were no extrapyramidal
signs. She showed dysmetria in the ﬁnger-to-nose and heel-to-shin
tests. She was unable to stand with her feet together. Her sensory and
autonomic systems were normal.
Patient 3 (Fig. 1, III-2), a 32-year-oldman, was the son of Patient 2. He
was healthy and did not show any abnormalities on physical and neuro-
logical examinations. He requested for MRI study for presymptomatic
testing. The unexpected MRI ﬁndings prompted genetic testing for
Alexander disease.
3.2. Laboratory ﬁndings
Laboratory examinations of our patients revealed normal values
including the blood cell counts; routine blood chemical test and uri-
nalysis results; clotting measures; thyroid functions; autoantibody
screening results; levels of anti-glutamic decarboxylase antibodies;
treponemal serology results; levels of anti-human T-lymphotropicFig. 1. Pedigree of the family with adult-onset Alexander disease. Numbers below each
symbol indicate the age at onset (o) and the age at the time of the most recent report
or death (d). Genotypes, where available, are indicated by a plus sign above a symbol.
Affected individuals are indicated by ﬁlled symbols, and individuals considered proba-
bly affected are shaded in gray. Empty symbols represent healthy subjects; oblique
slash, deceased; squares, male; circles, female.virus-I antibodies; and levels of anti-human immunodeﬁciency virus
antibodies, ceruloplasmin, copper, very long-chain fatty acids, vita-
min B12, and folic acid. Cerebrospinal ﬂuid analysis results were
also normal.
3.3. Brain and spinal cord MRI ﬁndings
The sagittal sections ofMR images showedmarked atrophy from the
medulla oblongata to the cervical cord in Patients 1 and 2 (Fig. 2A,B). In
contrast, in Patient 3, the son of Patient 2, cervicomedullary atrophy
was mild (Fig. 2C). Mild cerebellar atrophy (Fig. 2A–C) was also
noted. Abnormal hyperintensity signals in the medulla oblongata in
axial T2-weighted images were detected bilaterally in Patients 1 and 2
(Fig. 2D,E). The midbrain was involved with a very thin superﬁcial,
hyperintense rim on only ﬂuid-attenuated inversion recovery (FLAIR)
sections in Patients 1 and 2 (Fig. 2G,H). Abnormal hyperintensity signals
in the posterior part of the globus pallidus were detected bilaterally in
T2-weighted images in Patients 1 and 2 (Fig. 2J,K). In Patient 3, there
were no signal abnormalities in the medulla oblongata (Fig. 2F), the
midbrain (Fig. 2I), and the globus pallidus (Fig. 2L). No periventricular
lesions or leukoencephalopathy was detected. There were no lesions
in the white matter and there were no contrast-enhanced lesions.
In Patient 1, brain CT showed marked atrophy of the medulla
oblongata. However, there was no calciﬁcation, and the cerebral
hemispheres were normal.
3.4. Molecular studies
We identiﬁed a novel heterozygous missense mutation in nucleo-
tide 232 (c.232G>A) in these three patients, which was not found in
78 normal control subjects. This mutation changed the codon at posi-
tion 78 of the human GFAP complementary DNA from GAC (aspartic
acid) to AAC (asparagine) (p.D78N).
4. Discussion
We present here a new Japanese family with adult-onset Alexan-
der disease with a novel mutation (p.D78N) in the GFAP gene. This
mutation occurs within a highly conserved segment of the GFAP
protein, and another nonsynonymous mutation of the same amino
acid (p.D78E) was already known as the cause of histopathologically
proven adult-onset Alexander disease [6], suggesting that our novel
p.D78N mutation is also likely to be disease-causing. Although both
symptomatic patients showed late-onset in our Japanese family, most
of the patients in the p.D78E mutation family reported by Stumpf et al.
[6] showed adult-onset with one individual showing juvenile onset.
Interestingly, missense mutations are also present at the adjacent
positions 76 (p.L76F, p.L76V) and 77 (p.N77S, p.N77Y), which produce
more severe effects, leading to the infantile-onset phenotype [7,8]. On
the other hand, a mutation at residue 79 (p.R79P, p.R79H, p.R79C,
p.R79G, p.R79S, p.R79L) is common with infantile or juvenile-onset
[7–9], but some patients in this mutation (p.R79H, p.R79C) showed
adult-onset [9,10]. The genotype–phenotype correlation in Alexander
disease appears to be complicated, and further studies are required to
establish ﬁrm these correlation.
Our patients demonstrated the bulbar signs and ataxia with exag-
gerated tendon reﬂexes, which are cardinal symptoms of adult-onset
Alexander disease, but did not show the exceptional symptoms ob-
served in the Canadian family with the analog p.D78E mutation [6],
such as dysautonomia (i.e., severe constipation, hypothermia, and hy-
potension), sleep apnea, and dysmorphism (i.e., progressive kyphosis,
arched palate, and short neck). In turn, the characteristic feature of
our patients is the involvement of the bilateral basal ganglia, as
shown by MRI, which is rare in adult-onset Alexander disease. To
date, at least four cases of adult-onset Alexander disease with
hyperintensity signals in the basal ganglia on T2-weighted MR images
Fig. 2.MR images of three patients. The sagittal sections of the brain and spinal MR images showmarked atrophy from the medulla oblongata to the cervical cord in Patients 1 and 2
(A, Patient 1, B, Patient 2). In Patient 3 (C), atrophy of these regions is mild. T2-weighted axial sections reveal abnormal hyperintensity signals in the medulla oblongata in Patient 1
(D, arrows) and Patient 2 (E, arrows). Hyperintensity signals in the midbrain peripheral rim are only detected on ﬂuid-attenuated inversion recovery (FLAIR) images in Patient 1 (G,
arrows) and Patient 2 (H, arrows). Atrophy of the midbrain tegmentum is also present in Patient 1 (G) and Patient 2 (H), but not in Patient 3 (I). Abnormal high-intensity signals in
the posterior part of the globus pallidus are detected in T2-weighted images of Patient 1 (J, arrows) and Patient 2 (K, arrow). Enlargement of the third ventricle is also noted in
Patient 1 (J) and Patient 2 (K), but not in Patient 3 (L). In Patient 3, there are no signal abnormalities in the medulla oblongata (F), the midbrain (I), and the globus pallidus (L).
T2-(B,C,D,E,F,J,K,L) and FLAIR (A,G,H,I)-weighted images of the brain.
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eral putamen [12], the anterior part of the globus pallidus [13], and the
posterior part of the globus pallidus [14]. The ﬁndings of these previous
studies, except for Namekawa et al. [14], do not resemble those of our
patients. Namekawa et al. [14] reported the case of one patient with
adult-onset Alexander disease with the R276L mutation and whose
MR images showed bilateral T2-weighted hyperintensity signals in
the posterior part of the globus pallidus, as in our patients. Therefore,
the symmetrical signal abnormalities of the basal ganglia, particularly
the posterior part of the globus pallidus, are rare ﬁndings in adult-
onset Alexander disease. Despite the basal ganglia involvement
detected byMRI, both Patients 1 and 2 in our study did not show extra-
pyramidal signs and symptoms. In the patient with basal ganglia in-
volvement previously reported by Namekawa et al. [14], axial rigidity,bradykinesia, and retropulsion were observed. However, they stated
that the parkinsonismof their patientwas uncertain because spastic pa-
resis masked the parkinsonism. In contrast, extrapyramidal symptoms
indicative of basal ganglia involvement have been rarely observed
in some patients with adult-onset Alexander disease [Patient 1 in refs.
[2,14–16]]. The association between clinical symptoms and signal ab-
normalities involving the basal ganglia onMR images is unclear. Further
studies of the clinical and radiological characteristics of adult-onset
Alexander disease are required.
Patient 3 in our study was asymptomatic and his MRI ﬁndings
showed mild atrophy of the medulla oblongata and upper cervical
cord, without abnormal hyperintensity signals and contrast enhance-
ment. To date, only four cases of asymptomatic adult-onset Alexander
disease, detected from MR images of the brain, have been reported
164 Y. Wada et al. / Journal of the Neurological Sciences 331 (2013) 161–164[the two patients reported in refs. [3] and [5] are referred to as
Patients 5 and 9 in both papers, respectively, Patient II.3 in ref. [12],
and Patient 3 in ref. [17]]. Only the patient of Okamoto et al. [17]
showed severe atrophy of the medulla oblongata and spinal cord
without abnormal hyperintensity signals on T2-weighted MR images,
as in our Patient 3. However, that of Balbi et al. [12] showed atrophy
of the medulla oblongata with symmetrical long-tract alterations, and
those of Farina et al. [5] showed atrophy and abnormal hyperintensity
signals on T2-weighted MR images of the medulla oblongata and
spinal cord, which are also observed in symptomatic patients with
adult-onset Alexander disease. It has been speculated that atrophy
of the medulla oblongata and cervical spinal cord in patients with
adult-onset Alexander disease might result from tissue damage relat-
ed to abnormal signal changes and persistent (although diminishing)
patchy areas of an abnormal blood–brain barrier, restricted to the
medulla oblongata [6,18]. Stumpf et al. [6] speculated that abnormal
signal changes in the medulla oblongata represent an early stage of
adult-onset Alexander disease, with later evolution toward marked
atrophy and degeneration of brainstem structures. Romano et al.
[18] reported their case of one patient with adult-onset Alexander
disease, whose MR images showed lesions in the medulla oblongata
and upper cervical spinal cord with marked signal changes and
persistent patchy areas of an abnormal blood–brain barrier; progres-
sive atrophy of the medulla oblongata and spinal cord was observed
from 4 to 6 years later. The absence of lesions, abnormal signal
changes, and contrast enhancement of the medulla oblongata and
upper spinal cord in our Patient 3 indicates that, in some rare cases
of asymptomatic relatives of patients affected by adult-onset Alexander
disease, the atrophy involving the medulla oblongata and upper spinal
cord might result from an insidiously progressive process, without ab-
normal signal changes [19].
In conclusion, we described here the new cases of patients from a
family with adult-onset Alexander disease showing a novel mutation
in the GFAP gene. In the cases of late-onset cerebellar ataxia of
unknown origin, particularly those with the typical atrophy of the
medulla oblongata and upper spinal cord detected by MRI, sequenc-
ing of the GFAP gene should be considered.Conﬂict of interest
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